Dermata Therapeutics Inc.

DRMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.15

$0 (0.00%)

At close: Sep 22, 2026, 4:00 PM ET

$1.22

+$0.07 (+6.09%)

After-hours: Sep 22, 2026, 7:42 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $783.79K

Enterprise Value $-3.63M

Beta 0.69

Average Volume 73.51K

Shares Outstanding (Diluted) 4.02M

Shares Change YoY 291.83%

Institutional Ownership 2.76%

Exchange NASDAQ

ISIN US2498455045

Price Performance

Price Change 1M -19.6%

Price Change 3M -6.5%

Price Change 6M -21.2%

Price Change YTD -47.3%

Price Change 1Y -78.6%

Price Change 3Y -99.3%

Price Change 5Y -100.0%

1M CAGR (ann.) 4.5%

1Y CAGR (ann.) -79.9%

5Y CAGR (ann.) -83.9%

All-Time CAGR -83.8%

Valuation

PE Ratio -0.26

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS 1.00

PB Ratio 0.22

P/FCF Ratio -0.10

P/Adj. FCF Ratio -0.10

P/OCF Ratio -0.57

EV/Sales N/A

EV/EBIT 0.43

EV/EBITDA 0.43

EV/FCF 0.45

Earnings Yield -381.7%

FCF Yield -1039.2%

Adj. FCF Yield -1049.3%

Financial Health

Net Cash $4.41M

Total Debt $0

Cash & Short-Term Investments $4.41M

Total Assets $5.32M

Current Ratio 2.81

Quick Ratio 2.73

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -24.79

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -1.0%

Returns

Return on Assets -157.3%

Return on Equity -166.7%

Return on Invested Capital -246.6%

Return on Capital Employed -246.6%

Return on Tangible Assets -157.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 116.6%

EPS CAGR 5Y 84.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -2.2%

FCF CAGR 5Y -2.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 17, 2026

EPS Estimate (next Q) -$0.55

EPS Growth Est (next Q) -66.7%

Revenue Est (next Q) $25K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $6

Price Target Upside 421.7%

Cash Flow

Operating Cash Flow $-8.03M

Free Cash Flow $-8.14M

Adj. Free Cash Flow $-8.22M

FCF Per Share -$2.03

OCF Per Share -$2

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-8.6M

EBITDA $-8.49M

Net Income $-8.37M

EPS (Diluted) -$4.39

Revenue / Employee N/A

Profit / Employee $-929.85K

Employees 9